MannKind Corporation (GETTEX:NNFN) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of unstated Closed: US$50M raised · US$3.89 a share Buyers: Frazier Life Sciences Use of proceeds: To fund the $45 million CVR payment triggered by the FDA approval of Furoscix ReadyFlow | Aug 5, 2026 |